Baird analyst Jeff Johnson maintains $Stryker Corp (SYK.US)$ with a buy rating, and adjusts the target price from $378 to $405.
According to TipRanks data, the analyst has a success rate of 53.3% and a total average return of 12.2% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Stryker Corp (SYK.US)$'s main analysts recently are as follows:
Stryker's recent performance indicated a topline exceedance. Looking ahead to 2025, the expectation is for growth to be fueled by the introduction of new products, potential enhancements from mergers and acquisitions with an estimated seven deals projected to bolster growth, and the ongoing surge of Mako, particularly with two additional indications. The stance remains one of watchfulness until there is a stronger belief in sales and EPS outperformance relative to market expectations.
Stryker reported robust diversified results in the third quarter with revenues surpassing expectations. The company's implied organic growth rate falls slightly below its historical quarterly trend, yet despite the tough comparisons from Q4, it anticipates maintaining strong procedural trends, favorable pricing, and growth drivers for its products that support its sustained premium growth.
The firm noted that the third quarter was robust, marked by a reinvigoration of global organic growth reaching double-digits, a notable positive shift in orthopedic pricing for the first time in ten years, and earnings per share expansion at or surpassing the mid-teen percentages.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
貝雅分析師Jeff Johnson維持$史賽克 (SYK.US)$買入評級，並將目標價從378美元上調至405美元。
根據TipRanks數據顯示，該分析師近一年總勝率為53.3%，總平均回報率為12.2%。
此外，綜合報道，$史賽克 (SYK.US)$近期主要分析師觀點如下：
賽悍近期表現強勁，顯示了營收超標。展望2025年，預計增長將得到新產品推出的推動，可能由併購活動帶來的增強，預計將有七筆交易來支撐增長，並且持續湧現的Mako潛力，特別是有兩個額外的適應症。立場保持謹慎，直到更加確信銷售和每股收益相對市場預期表現的強勁信念。
Stryker在第三季度報告中宣佈強勁的多元化業績，收入超出預期。公司暗示的有機增長率略低於其歷史季度趨勢，儘管從第四季度進行了艱難的比較，但預計保持強勁的程序趨勢，有利的定價和產品增長驅動因素將繼續支持其持續的優質增長。
公司指出第三季度業績強勁，全球有機增長活力重現，增長率達到兩位數，整體正骨產品定價出現十年來第一次明顯轉變，每股收益擴張達到或超過中途回報的百分比。
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
